| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.6M | +633.1% |
| Cost of Revenue | $3.6M | +376.3% |
| Gross Profit | $2.0M | — |
| R&D Expense | $4.1M | -50.1% |
| SG&A Expense | $4.5M | -21.2% |
| Operating Income | -$10.0M | +45.6% |
| Interest Expense | $200K | +0.0% |
| Pre-tax Income | -$9.6M | +47.9% |
| Net Income | -$9.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.4M | +668.7% |
| Accounts Receivable | $3.0M | +3730.8% |
| Inventory | $1.5M | +203.0% |
| Current Assets | $15.3M | +426.1% |
| Total Assets | $16.7M | +341.2% |
| Current Liabilities | $3.7M | -25.0% |
| Total Liabilities | $4.2M | -12.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.4M | +29.3% |
| Capital Expenditures | $82K | -33.3% |
| Investing Cash Flow | -$82K | +33.3% |
| Financing Cash Flow | $21.6M | +321.5% |
| Free Cash Flow | -$12.5M | +29.4% |
| +47.9% |
| EPS (Basic) | -$6.46 | -151.4% |
| EPS (Diluted) | -$6.46 | -151.4% |
| Stockholders' Equity |
| $12.5M |
| +1260.4% |